Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$26.26 - $29.9 $108,427 - $123,457
-4,129 Reduced 20.64%
15,873 $418,000
Q1 2024

May 14, 2024

SELL
$27.46 - $31.33 $18.5 Million - $21.1 Million
-672,962 Reduced 97.11%
20,002 $607,000
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $17.4 Million - $19.4 Million
663,963 Added 2289.45%
692,964 $19.5 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $103,464 - $123,637
3,940 Added 15.72%
29,001 $787,000
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $5,061 - $6,251
171 Added 0.69%
25,061 $770,000
Q1 2023

May 17, 2023

SELL
$32.77 - $39.4 $2.26 Million - $2.72 Million
-69,113 Reduced 73.52%
24,890 $896,000
Q4 2022

Mar 06, 2023

SELL
$39.17 - $44.04 $362,596 - $407,678
-9,257 Reduced 8.96%
94,003 $3.72 Million
Q3 2022

Nov 02, 2022

BUY
$39.88 - $44.65 $134,515 - $150,604
3,373 Added 3.38%
103,260 $4.15 Million
Q2 2022

Aug 12, 2022

SELL
$37.53 - $44.22 $8,219 - $9,684
-219 Reduced 0.22%
99,887 $4.2 Million
Q1 2022

May 13, 2022

SELL
$37.46 - $42.44 $993,326 - $1.13 Million
-26,517 Reduced 20.94%
100,106 $3.9 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $1.58 Million - $1.9 Million
44,797 Added 54.75%
126,623 $5.05 Million
Q3 2021

Nov 12, 2021

BUY
$36.14 - $42.24 $2.39 Million - $2.8 Million
66,250 Added 425.33%
81,826 $2.96 Million
Q2 2021

Aug 10, 2021

BUY
$39.85 - $46.63 $122,419 - $143,247
3,072 Added 24.57%
15,576 $638,000
Q1 2021

May 11, 2021

SELL
$42.34 - $52.82 $57,540 - $71,782
-1,359 Reduced 9.8%
12,504 $545,000
Q4 2020

Feb 12, 2021

BUY
$36.12 - $50.05 $337,324 - $467,416
9,339 Added 206.43%
13,863 $693,000
Q3 2020

Nov 13, 2020

BUY
$38.56 - $48.36 $97,325 - $122,060
2,524 Added 126.2%
4,524 $190,000
Q2 2020

Aug 12, 2020

BUY
$44.5 - $52.11 $89,000 - $104,220
2,000 New
2,000 $97,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.